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Abstract
Objective. To study the microbial characteristics of patients with pelvic inﬂammatory disease (PID) and the possible impact
of an intrauterine device (IUD) on the microbial environment in women presenting with PID.
Methods. Case-control study, investigating 51 women with acute PID and 50 healthy women. Endocervical specimens for
microbiological investigation were obtained at gynaecological examination.
Results. IUD users with PID had signiﬁcantly more Fusobacteria spp. and Peptostreptococcus spp. than non-IUD users with
PID. The ﬁnding of combinations of several anaerobic or aerobic microbes was associated with a signiﬁcantly increased risk
of PID and with complicated PID. In IUD users, the combinations of several anaerobic/aerobic microbes were associated
with an increased risk of PID, irrespective of duration of IUD use. Long-term IUD use appeared to be associated with an
increased risk of a PID being complicated.
Conclusion. The ﬁnding of several anaerobic or aerobic microbes appears to be associated with PID in users of IUD.
Keywords: Pelvic inﬂammatory disease, intrauterine device, microbiology, anaerobes
Introduction
Pelvic inﬂammatory disease (PID) is the most
common gynaecological infection. PID is associated
with a high morbidity resulting from an inﬂammation
and damage of the reproductive tract that can lead to
sequelae such as tubal factor infertility, ectopic
pregnancy and chronic pelvic pain [1,2]. Many
studies have been carried out during the last four
decades to determine the microbiological aetiology
of PID. Mainly, they demonstrate a direct associa-
tion between PID and sexually transmitted infections
(STI) such as Chlamydia trachomatis and Neisseria
gonorrhoeae [1–4]. It is well established that the
highest PID and STI prevalence is found in sexually
active women below 25 and is directly related to
the sexual behaviour of both partners [1,2,4–6].
However, the bacterial pathogenesis of PID is
unclear in cases where STI microbes are not
detected, and where behavioural correlates of PID
are not apparent. Many authors mention the role of
facultative and anaerobic pathogens [4,5,7–10], as
well as Mycoplasma hominis and Ureaplasma urealy-
ticum [11], as aetiological factors in PID.
There is limited knowledge about the risk of PID
attributable to the use of an intrauterine device
(IUD). The use of IUDs and risk of PID has been a
topic for discussions between clinicians and re-
searchers ever since IUDs were introduced. In
particular, the possible inﬂuence of an IUD on the
microbiological ﬁndings in the female genital tract
and the impact of an IUD on the ascension of
pathogens and on the severity of PID have been
extensively discussed [4,12–14]. Following the
concern associated with the ‘Dalkon shield’ type of
IUD, WHO conducted a large study, and one
important conclusion was that the risk of PID related
to IUD use has been exaggerated [15].
According to a recent survey (1997) 20.3% of
women aged 15 to 45 in Latvia use IUDs, making
IUDs the most common contraceptive method used.
Since the 1990s only copper releasing IUDs have
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relationship between IUD use and PID has been
performed. This study was designed as a case-control
study to test the following hypotheses: IUD users
have a higher risk of PID than non-users, IUD users
have more severe clinical characteristics of PID than
non-users, IUD users have a more complicated
clinical course of PID than non-users, and IUD
users have different microbiological ﬁndings com-
pared with non-users. Some descriptive results from
the study have already been presented [16]. The
purpose of this report is to present the microbiolo-
gical ﬁndings.
Material and methods
Study population and deﬁnitions
The cases studied were women admitted to hospital
with a diagnosis of acute PID. Women, who were
healthy and attended outpatient clinics for routine
gynaecological check-ups without any complaints,
served as controls. A detailed description of the
protocol, clinical criteria for PID cases, and inclusion
and exclusion criteria for the study group have been
presented elsewhere [16].
In brief, at the time of recruitment women had to
be aged 25–45, and, if the case or control woman was
an IUD user, the IUD usage had to exceed one
month in order to avoid directly post-insertion related
complications [13,17]. A complicated PID case was
deﬁned upon the clinical ﬁndings at admission of a
palpable adnexal tumor (bilateral or unilateral) and
elevated body temperature and at least one of
three of the following laboratory signs: leukocyte
count 510000/mm
3, erythrocyte sedimentation
rate 515 mm/h or C–reactive protein 520 mg/l.
A case was also retrospectively deﬁned as compli-
cated if treatment required surgery (unilateral or
bilateral salpingectomy or adnexectomy).
Between December 1998 and January 2001, all
51 women admitted to Riga 1st Hospital, Dzelzcel-
nieku Hospital and Lags-Centrs Hospital (Riga,
Latvia), who were diagnosed with acute PID
according to established criteria, were asked to
participate in the study by a duty gynaecologist.
During the same period, among all healthy con-
secutive outpatient clinic visitors, 50 women, who
met the inclusion and exclusion criteria, were asked
to participate as controls by the principal investigator
during her work hours.
The purpose of the study was presented to every
eligible woman and she was asked to sign an informed
consent form. Some results from the study have
already been presented [16]. In summary, women
with PID (cases) differed signiﬁcantly from healthy
controls in that they were slightly older, had spent less
time in education, were more likely to be unemployed
and were more often smokers. The cases also
reported longer time since last pregnancy and longer
use of current contraceptive method than healthy
controls. However, there were no signiﬁcant differ-
ences between cases and controls with regard to
typical risk factors for PID such as age at ﬁrst
intercourse, number of sex partners, duration of
current sexual relationship, number of previous
pregnancies and previous episodes of PID. IUD use
was common in both cases (55%) and controls (40%)
and this difference was not statistically signiﬁcant.
Study methods
All participants were asked to complete a structured
questionnaire about life habits, sexual behaviour, and
contraceptive use, and reproductive, gynaecological
and medical histories were taken during the out-
patient visit (controls) or during the hospital stay
(cases). All cases were treated in-clinic.
Microbiological investigation
On admission, all women, both cases and controls,
underwent a gynaecological examination, and
endocervical specimens for microbiological investi-
gation were obtained. Specimens were number-
coded according to the case/control questionnaire,
collected and transported by the principal investiga-
tor. For transportation of bacteriological material,
transport-media (‘Amies’) with charcoal was used.
The transportation time did not exceed 12 hours.
For identiﬁcation of DNA of N. gonorrhoeae and
C. trachomatis, material was transported in the
medium ‘Digene’. Material from endocervix was
Gram-stained, cultured and DNA of N. gonorrhoeae
and C. trachomatis was identiﬁed. Microbiological
analysis was performed at the Department of
Microbiology of Riga Stradins University and the
Laboratory of Virology of a State agency, the ‘Public
Health Agency’. Methods used for identiﬁcation of
microorganisms are summarized in Table I.
Statistical methods
All data were analyzed and compared between
groups using the SAS statistical package. Frequency
tables were analyzed using Fisher’s Exact test. Odds
ratios were calculated and tested with Wald’s test
where appropriate. In all analyses, a p-value50.05
was considered signiﬁcant. The calculation of sample
size with the statistical power 80% was based on the
percentage of IUD use in Latvia’s female population,
and the assumption, based on clinical observation in
Latvia, that approximately half of PID case women
above 25 years of age use an IUD.
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Results
The endocervical microbial proﬁle
The microbiological results are presented for the case
group in comparison with the control group and for
women with and without IUDs among cases as well
as among controls (Table II). The microbiological
results are shown for uncomplicated cases compared
with complicated cases of PID and results are
presented for those groups with regard to IUD use
or non-IUD use (Table III).
STI microbes. Only one case of N. gonorrhoeae was
found in a woman with PID and three cases of
C. trachomatis were detected, all of which were found
in the healthy controls.
Aerobic bacteria. There were no signiﬁcant differences
between healthy and ill women, between uncompli-
cated and complicated PID cases, or between IUD
users and non-users in the PID group with regard to
all detected aerobic microbes. Ureaplasma urealyti-
cum was signiﬁcantly more often detected in healthy
IUD users than in healthy non-users (p=0.034).
Anaerobic bacteria. Regarding anaerobic bacteria,
there was no signiﬁcant difference between PID
women and healthy controls, or between uncompli-
cated and complicated cases of PID. However, IUD
users among women with PID had signiﬁcantly more
Fusobacteria spp. (p=0.006) and Peptostreptococcus
spp. (p=0.021) than did non-users with PID.
Facultative anaerobic bacteria. Lactobacillus spp. was
signiﬁcantly less frequently found in the PID group
than in the control group (p=0.013), but there was
no signiﬁcant difference between complicated and
uncomplicated cases of PID or between IUD users
and non-users.
Synergism between microbes
In order to test the hypothesis of whether there is a
synergistic effect between several microbes in the
pathogenesis of PID, the ﬁve most frequently
detected microbes were included in the analyses.
Among aerobic microbes Staphylococcus spp. and
Streptococcus spp. and among anaerobes Bacterioides
spp., Fusobacteria spp. and Peptostreptococcus spp.
were included in the analysis.
Risk of PID and risk of a PID being complicated
according to the endocervical microbial proﬁle. The risk
for a woman of having a PID and the risk
for a woman with PID to be a complicated case
according to the polymicrobial environment in the
endocervix, was tested using a univariate analysis of
data (Table IV). The ﬁnding of at least two anaerobic
microbes was associated with a PID diagnosis
(OR=2.8; CI 1.04–7.6). Similarly, the ﬁnding of at
least three aerobic or anaerobic microbes was
associated with an increased risk of PID (OR=2.4;
CI 1.04–5.9). In women with PID, the ﬁnding of at
least two anaerobic microbes was associated with an
increased risk of the PID being complicated
(OR=4.0; CI 1.07–14.9). Stratifying for age, the
association between the ﬁnding of at least two
anaerobic microbes or at least three aerobic or
anaerobic microbes and the risk of PID or the risk
of a PID being complicated appeared stronger in
women over 35. This ﬁnding was, however, not
statistically signiﬁcant.
Risk for an IUD user of having a PID or complicated
PID according to the endocervical microbial proﬁle. In
order to assess the role of IUDs, and, in particular,
Table I. Identification methods for microorganisms.
Anaerobic bacteria spp.: bacteriological method, bacteria were incubated in Schaedler agar with
5% sheep blood in ‘Genbag anaer.’ with further identification
of biochemical properties and antigenic structure
Mycoplasma hominis, Ureaplasma urealyticum: bacteriological method, Mycoplasma Lyo medium, Bio-Merieux
Trichomonas vaginalis: bacteriological method, Trichosel broth, BBL
Streptococcus spp.: bacteriological method, Columbia blood agar, Bio-Merieux and Slidex strepto
for identification of groups
Staphylococcus spp.: bacteriological method, Columbia blood agar, Chapman’s agar, Bio-Merieux
and Slidex staphylo for identification of S. aureus
Candida spp.: bacteriological method, Sabouraud chloramphenicol agar and API 32C system
for yeast identification
Actinomyces spp.: bacteriological method, Columbia blood agar, Bio-Merieux
Gardnerella vaginalis: smear, Gram-stained
Neisseria gonorrhoeae, Chlamydia trachomatis: DNA Digene C, G test (Hybrid Capture II System), general primers GP5,6
Endocervical microbial ﬁndings in women with PID 185T
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Endocervical microbial ﬁndings in women with PID 187the duration of use, on the risk of PID, IUD users
were analysed separately from non-users with
regard to microbial ﬁndings (Table V). The ﬁnding
of at least two anaerobic microbes (OR=9.0,
CI 1.8–46.3) or at least three aerobic or anaerobic
microbes (OR=4.0, CI 1.1–15.0) in an IUD user
was statistically signiﬁcantly associated with PID.
Among IUD users with PID, no statistically sig-
niﬁcant association was found between any com-
bination of aerobic or anaerobic microbes and the
risk of having a complicated PID. Stratifying data by
duration of usage of IUD (55 years and 45 years)
did not reveal an overall higher risk in women with
long (45 years) usage of IUD. However, long
duration of IUD use together with the ﬁnding of
at least two anaerobic microbes appeared to be
associated with an increased, although not statisti-
cally signiﬁcant, risk of complicated PID (OR=3.0,
CI 0.2–41.0).
Risk for an IUD non-user to have a PID or complicated
PID according to the endocervical microbial proﬁle.
When IUD non-users were analysed separately with
the same approach there was no statistically sig-
niﬁcant OR for PID with any combination of aerobic
or anaerobic microbes in the endocervix (Table VI).
Table IV. The risk of having PID in 51 cases and 50 controls and the risk of having a complicated PID in 24 uncomplicated cases and 27
complicated cases, based on endocervical microbial profile and stratified by age groups.
Study group (101) PID group (51)
OR CI 95% p-value* OR CI 95% p-value*
At least two anaerobic microbes 2.8
a 1.04–7.6 0.042 4.0
a z1.07–14.9 0.039
25–34 years 1.6 0.4–7.3 0.522 0.7 0.1–8.5 0.796
535 years 3.0 0.7–13.0 0.143 8.5 0.9–83.1 0.064
At least three aerobic or anaerobic microbes 2.4
a 1.04–5.9 0.041 1.9 0.6–5.8 0.285
25–34 years 1.9 0.6–5.8 0.283 0.5 0.1–3.5 0.496
535 years 4.9 0.9–25.8 0.062 8.6 0.9–83.1 0.064
*Wald’s test;
aStatistically significant.
Table V. The risk of having PID among 48 women with IUD (A; 28 PID women and 20 healthy women) and the risk of having a
complicated PID among 28 PID women with IUD (B; 7 uncomplicated cases and 21 complicated cases), based on endocervical microbial
profile and stratified by IUD usage length.
A (48) B (28)
OR CI 95% p-value* OR CI 95% p-value*
At least two anaerobic microbes 9.0
a 1.8–46.3 0.009 1.5 0.3–8.2 0.663
55 years 9.3 0.9–101.9 0.067 0.5 0.04–6.7 0.6
55 years 5.0 0.5–54.0 0.185 3.0 0.2–41.0 0.410
At least three aerobic or anaerobic microbes 4.0
a 1.1–15.0 0.04 3.3 0.5–21.3 0.203
55 years 4.0 0.7–23.5 0.125 6.0 0.4–101.6 0.215
55 years 4.0 0.4–43.1 0.253 2.3 0.2–31.0 0.534
*Wald’s test;
aStatistically significant; NE, not estimated.
Table VI. The risk of having PID among 53 women without IUD (A; 23 PID women and 30 healthy women) and the risk of having a
complicated PID among 23 PID women without IUD (B; 17 uncomplicated cases and 6 complicated cases), based on endocervical
microbial profile.
A (53) B (23)
OR CI 95% p-value* OR CI 95% p-value*
At least two anaerobic microbes 0.5 0.1–2.7 0.403 3.2 0.2–61.0 0.439
At least three aerobic and anaerobic microbes 1.4 0.4–4.9 0.562 0.4 0.03–4.0 0.406
*Wald’s test.
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The decision to collect data on women with the age
restriction 525 was made to avoid the traditional
risk factors for PID and, thus, to investigate if and to
what extent IUD use per se could account for
microbiological differences and the aetiology of
PID. Surprisingly few cases with N. gonorrhoeae
and C. trachomatis were detected. It is unlikely that
this lack of common STI pathogens is due to
methodological imprecision, since the method used
for the analysis is highly sensitive and speciﬁc for the
detection of those sexually transmitted microbes
[18]. This ﬁnding might rather be explained by the
absence of classical risk factors for STI in our study
group and there were no difference between women
with PID and healthy controls with regard to
common risk factors for STI [16].
Lactobacillus spp. is the dominant microbe in the
vaginal-endocervical ecosystem of healthy women
and is believed to act as a defence factor inhibiting
aerobic and anaerobic microbe growth and colonisa-
tion [19]. Lack of this dominance could promote
overgrowth of endogenous aerobic and anaerobic
bacteria and, subsequently, promote the develop-
ment of PID, explaining the difference found
between healthy and ill women.
Some reports have shown an association between
bacterial vaginosis (BV) and IUD use [20,21], but in
the present study the occurrence of BV was not
investigated. The more frequent ﬁnding in IUD
users of Fusobacteria spp. and Peptostreptococcus spp.
is difﬁcult to explain. Those Gram-positive anaero-
bic cocci are a major part of the normal human ﬂora
of the large bowel in general and of the female
genitourinary system in particular. Counts are
known to vary with physiological processes such as
the menstrual cycle and pregnancy, which makes
assessment of the normal ﬂora complicated. The
sampling in the study was not stratiﬁed for time in
the menstrual cycle and only a minority of non-IUD
users were on steroidal contraceptives.
There is considerable debate whether anaerobes
can act as primary pathogens or only as secondary
invaders when the urogenital tract is already
damaged, or whether they are important components
of a synergistic group of pathogens. The pathogeni-
city of anaerobes has been little studied. A series of
experiments and a few studies have shown that most
species of anaerobes express their pathogenicity via a
synergistic interaction with facultative organisms or
other anaerobes [9,10]. Anaerobic bacteria elaborate
a variety of potential virulence factors, but little is
known about circumstances when and why and how
anaerobes cause disease [9,10]. There are no clear
data about the prevalence and activity of anaerobes
in the vaginal ecosystem in IUD users. Moreover, in
studies on the microbiological proﬁle of healthy
women prior to IUD insertion, during follow-up and
microbiological investigation of removed IUDs of
healthy women and of women with PID, there is a
diversity of detected microbes and researchers have
come to different conclusions [22–25]. From the
present study, it appears as if IUD use could
promote the growth of anaerobes and, thus, play a
role in the expression of their virulence factors in the
development of PID.
From the present study it appears that synergism
between combinations of microbes plays an important
role in the development of PID. The study also
supports the hypothesis that IUD use together with the
occurrence of combinations of anaerobic/aerobic
microbes may facilitate the development of PID. The
impact of IUD use on the development of PID is
supported by the ﬁnding that, among IUD non-users,
no microbial combination affected the risk of PID.
With regard to the duration of IUD use, the study
could not conﬁrm that long duration of use was a
particular risk factor for PID in general, whereas long
duration of use was associated with a high risk of
having a complicated PID, suggesting that the dura-
tion of IUD use may still be important. There appears
to be a tendency that older age (535) increases the
risk of PID, but in the present study, there were too
few women over 35 to reach statistical signiﬁcance.
Actinomyces are part of the normal vaginal ﬂora,
but complicated PID, associated with Actinomyces,
has been reported in the literature, especially among
IUD users [26]. Understanding of the pathogenesis
of pelvic actinomycosis and why it correlates with
IUD use is poor and controversial. In the present
study, there were too few cases of Actinomyces to
show a clear impact on the development of PID,
although Actinomyces were found slightly more often
in IUD users with PID.
A possible limitation in the study could be the
selection of the control women, who were selected
on the assumption that they were likely to be similar
to the women with PID in most respects. Healthy
women suitable to serve as controls are difﬁcult to
identify and there is no population base in Latvia
where ideal controls could be found. The control
women represented healthy women in general who
followed the common national recommendation
to have a routine gynaecological check-up and,
although they differed slightly in age, both PID
women and healthy controls were similar with regard
to previous gynaecological morbidity and attendance
to a gynaecologist during the last year as well as
sexual behaviour and contraceptive use [16].
In conclusion, whereas there was little difference
between groups with regard to single microbes, the
ﬁnding of combinations of several anaerobic or
aerobic/anaerobic microbes appears to be associated
Endocervical microbial ﬁndings in women with PID 189with PID, particularly in women over 35. Long-term
IUD use may possibly be associated with an
increased risk of developing a complicated PID.
The study supports the hypothesis that the patho-
genesis of non-sexually transmitted PID is associated
with a synergistic effect between several pathogens,
possibly facilitated by the presence of an IUD.
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